4.6 Review

Latest Contributions of Genomics to T-Cell Acute Lymphoblastic Leukemia (T-ALL)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia

Llucia Alberti-Servera et al.

Summary: T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive leukemia characterized by chromosomal rearrangements and somatic mutations in protein-coding regions. Most T-ALL cases have activating mutations in NOTCH1 and other genes related to signaling and regulation. Single-cell DNA sequencing reveals clonal architecture and evolution in T-ALL, showing major and minor clones at diagnosis and during treatment.
Article Pharmacology & Pharmacy

Effects of NT5C2 Germline Variants on 6-Mecaptopurine Metabolism in Children With Acute Lymphoblastic Leukemia

Chuang Jiang et al.

Summary: Germline variations in the NT5C2 gene significantly contribute to interpatient variability in thiopurine drug disposition, affecting 6-MP metabolism and leading to differences in drug distribution among patients.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Article Hematology

Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine

Kiyomi Morita et al.

Summary: Patients with ETP-ALL/LBL have poor survival rates, while the outcomes of near-ETP ALL/LBL are similar to non-ETP ALL/LBL. Allogeneic stem cell transplant benefits ETP-ALL/LBL but not near-ETP or non-ETP ALL/LBL. The addition of nelarabine to hyper-CVAD improves survival only in non-ETP ALL.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Review Biochemistry & Molecular Biology

DNA Methylation in T-Cell Acute Lymphoblastic Leukemia: In Search for Clinical and Biological Meaning

Natalia Mackowska et al.

Summary: Distinct DNA methylation signatures in T-ALL are associated with different prognosis, reflecting both the replicative history of leukemic cells and underlying mechanisms in leukemia development. Investigating methylation phenotypes may pave the way for predictive diagnostics and precision medicine in T-ALL, highlighting technological advancements in understanding the role of this epigenetic modification.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Hematology

Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia

Josep-Maria Ribera et al.

Summary: The study evaluated the outcomes of high-risk Ph- adult ALL patients treated with chemotherapy or allo-HSCT, finding that avoiding allo-HSCT for patients with adequate MRD response does not affect outcomes.
Article Hematology

14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia

Danika Di Giacomo et al.

Summary: The study identified a distinct subgroup of immature acute leukemias characterized by 14g32/BCL11B translocations, including AML, TIM MPAL, and ETP-ALL. These translocations activate BCL11B, whose expression behaves as a disease biomarker present at diagnosis and co-occurs with variants at FLT3 and epigenetic modulators. Transcriptome analysis revealed a specific expression signature separating BCL11B AL from AML, T-ALL, and ETP-ALL, with an ex vivo drug-sensitivity profile identifying effective antileukemic compounds.
Article Oncology

Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing

Scott Newman et al.

Summary: This study utilized a three-platform sequencing approach, including WGS, WES, and RNAseq, to examine tumor and germline genomes from 309 children with pediatric cancers. The study revealed the presence of diverse genetic variants in most patients, with WGS helping to detect activating gene fusions, enhancer hijacks, small intragenic deletions, and mutational signatures. The evaluation of paired tumor-normal data showed the relevance of pathogenic germline variants to tumor development in a significant portion of cases.

CANCER DISCOVERY (2021)

Article Oncology

Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia

Lindsey E. Montefiori et al.

Summary: This study identified a subgroup of acute leukemias with ambiguous lineage expressing myeloid, T lymphoid, and stem cell markers, driven by aberrant allele-specific deregulation of the master transcription factor BCL11B. Chromosomal rearrangements and focal amplifications leading to superenhancer generation were identified as mechanisms behind the oncogenic deregulation of BCL11B. This ectopic expression of BCL11B in hematopoietic cells mediated by enhancer hijacking was suggested as an oncogenic driver of human lineage-ambiguous leukemia.

CANCER DISCOVERY (2021)

Article Oncology

A Tumor Suppressor Enhancer of PTEN in T-cell Development and Leukemia

Luca Tottone et al.

Summary: A PTEN enhancer, PE, recurrently deleted in T-ALL patients, leads to reduced PTEN levels in T cells and accelerated development of NOTCH1-induced leukemia in vivo. This suggests that long-range regulation of tumor suppressor genes is a significant mechanism in cancer.

BLOOD CANCER DISCOVERY (2021)

Article Medicine, Research & Experimental

Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia

Yizhen Li et al.

Summary: Genetic alterations in the RUNX1 gene are associated with various blood disorders, especially those of the megakaryocyte and myeloid lineages. Germline RUNX1 variants have different effects on B-ALL and T-ALL, with the latter showing severe damaging effects. Additionally, JAK3 mutation is a common somatic genomic abnormality in T-ALL with germline RUNX1 variants.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Biotechnology & Applied Microbiology

The evolution of relapse of adult T cell acute lymphoblastic leukemia

Ines Sentis et al.

GENOME BIOLOGY (2020)

Article Oncology

Genome-Wide Association Study of Susceptibility Loci for T-Cell Acute Lymphoblastic Leukemia in Children

Maoxiang Qian et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Article Oncology

Mechanisms of NT5C2-Mediated Thiopurine Resistance in Acute Lymphoblastic Leukemia

Takaya Moriyama et al.

MOLECULAR CANCER THERAPEUTICS (2019)

Article Oncology

Incidence and survival of T-cell acute lymphoblastic leukemia in the United States

Guru Subramanian Guru Murthy et al.

LEUKEMIA & LYMPHOMA (2019)

Article Biochemistry & Molecular Biology

CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia

Woori Jang et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

Pathogenic Germline Variants in 10,389 Adult Cancers

Kuan-lin Huang et al.

Article Biochemistry & Molecular Biology

Somatic mutations precede myeloid leukemia years before diagnosis

Pinkal Desai et al.

NATURE MEDICINE (2018)

Review Cell & Tissue Engineering

Concise Review: Age-Related Clonal Hematopoiesis: Stem Cells Tempting the Devil

Lambert Busque et al.

STEM CELLS (2018)

Article Biochemistry & Molecular Biology

High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics

Maurizio Pellegrino et al.

GENOME RESEARCH (2018)

Article Multidisciplinary Sciences

The genetic basis and cell of origin of mixed phenotype acute leukaemia

Thomas B. Alexander et al.

NATURE (2018)

Article Multidisciplinary Sciences

Prediction of acute myeloid leukaemia risk in healthy individuals

Sagi Abelson et al.

NATURE (2018)

Article Oncology

Deletion 6q Drives T-cell Leukemia Progression by Ribosome Modulation

Stephanie Gachet et al.

CANCER DISCOVERY (2018)

Article Biotechnology & Applied Microbiology

RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures

Maurizio Pellegrino et al.

BMC GENOMICS (2016)

Article Multidisciplinary Sciences

Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia

Koichi Oshima et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Oncology

The genetics and mechanisms of T cell acute lymphoblastic leukaemia

Laura Belver et al.

NATURE REVIEWS CANCER (2016)

Review Multidisciplinary Sciences

Realizing the promise of cancer predisposition genes

Nazneen Rahman

NATURE (2014)

Article Biochemistry & Molecular Biology

A NOTCH 1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia

Daniel Herranz et al.

NATURE MEDICINE (2014)

Article Medicine, General & Internal

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

Siddhartha Jaiswal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Hematology

Inherited Predisposition to Acute Myeloid Leukemia

Lucy A. Godley

SEMINARS IN HEMATOLOGY (2014)

Article Multidisciplinary Sciences

The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes

Robert Huether et al.

NATURE COMMUNICATIONS (2014)

Article Multidisciplinary Sciences

Signatures of mutational processes in human cancer

Ludmil B. Alexandrov et al.

NATURE (2013)

Article Biochemistry & Molecular Biology

Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL

Gannie Tzoneva et al.

NATURE MEDICINE (2013)

Article Biochemistry & Molecular Biology

The Origin and Evolution of Mutations in Acute Myeloid Leukemia

John S. Welch et al.

Article Multidisciplinary Sciences

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

Jinghui Zhang et al.

NATURE (2012)

Article Immunology

ETV6 mutations in early immature human T cell leukemias

Pieter Van Vlierberghe et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2011)

Review Cell Biology

Rare genetic variants and the risk of cancer

Walter Bodmer et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)

Article Biochemistry & Molecular Biology

Cytosolic high Km 5′-nucleotidase and 5′(3′)-deoxyribonucleotidase in substrate cycles involved in nucleotide metabolism

C Gazziola et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)